Shigella

Last updated: June 20, 2025

Shigella

Watch later

Watch later

Action potentials in myocytes
Action potentials in pacemaker cells
Excitability and refractory periods
Cardiac excitation-contraction coupling
Antidiuretic hormone
Calcitonin
Phosphate, calcium and magnesium homeostasis
Vitamin D
Blood components
Innate immune system
Complement system
Cytokines
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
B- and T-cell memory
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Bone remodeling and repair
Muscular system anatomy and physiology
Neuromuscular junction and motor unit
Slow twitch and fast twitch muscle fibers
Muscle spindles and golgi tendon organs
Muscle contraction
Sliding filament model of muscle contraction
Nervous system anatomy and physiology
Neuron action potential
Adrenergic receptors
Sympathetic nervous system
Parasympathetic nervous system
Cholinergic receptors
Body fluid compartments
Movement of water between body compartments
Hydration
Renin-angiotensin-aldosterone system
Sodium homeostasis
Potassium homeostasis
Osmoregulation
Necrosis and apoptosis
Hypoxia
Ischemia
Inflammation
Wound healing
Oncogenes and tumor suppressor genes
Hyperplasia and hypertrophy
Atrophy, aplasia, and hypoplasia
Metaplasia and dysplasia
Pharmacodynamics: Drug-receptor interactions
Enzyme function
Pharmacodynamics: Agonist, partial agonist and antagonist
Pharmacodynamics: Desensitization and tolerance
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug metabolism
Cholinomimetics: Direct agonists
Muscarinic antagonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Sympathomimetics: Direct agonists
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Anticoagulants: Heparin
Anticoagulants: Warfarin
Monoclonal antibodies
Glucocorticoids
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
Antimetabolites: Sulfonamides and trimethoprim
DNA synthesis inhibitors: Metronidazole
Mechanisms of antibiotic resistance
Protein synthesis inhibitors: Aminoglycosides
Miscellaneous cell wall synthesis inhibitors
Integrase and entry inhibitors
Protease inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Azoles
Miscellaneous antifungal medications
Echinocandins
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Parathyroid conditions and calcium imbalance: Clinical
Parathyroid disorders and calcium imbalance: Pathology review
DNA replication
Transcription of DNA
DNA mutations
Translation of mRNA
Proteins
Resting membrane potential
Demyelinating disorders: Pathology review
Blood groups and transfusions
Microcirculation and Starling forces
Bacterial structure and functions
Staphylococcus epidermidis
Staphylococcus aureus
Staphylococcus saprophyticus
Streptococcus pneumoniae
Clostridium perfringens
Clostridium botulinum (Botulism)
Clostridium tetani (Tetanus)
Clostridium difficile (Pseudomembranous colitis)
Escherichia coli
Salmonella (non-typhoidal)
Enterobacter
Shigella
Vibrio cholerae (Cholera)
Campylobacter jejuni
Mycoplasma pneumoniae
Viral structure and functions
Varicella zoster virus
Human herpesvirus 8 (Kaposi sarcoma)
Epstein-Barr virus (Infectious mononucleosis)
Herpes simplex virus
Human herpesvirus 6 (Roseola)
Adenovirus
Human papillomavirus
Rhinovirus
Influenza virus
Norovirus
Rotavirus
Vaccinations
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Introduction to the lymphatic system
Mendelian genetics and punnett squares
Inheritance patterns
Muscular dystrophies and mitochondrial myopathies: Pathology review
Autosomal trisomies: Pathology review
Miscellaneous genetic disorders: Pathology review
Independent assortment of genes and linkage
DNA structure
Nuclear structure
Amino acids and protein folding
Gene regulation
Lac operon
Karyotyping
Gel electrophoresis and genetic testing
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
DNA cloning
Down syndrome (Trisomy 21)
Huntington disease
Williams syndrome
Cystic fibrosis
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Deep vein thrombosis
Deep vein thrombosis and pulmonary embolism: Pathology review
Immunodeficiencies: Clinical
Selective immunoglobulin A deficiency
Isolated primary immunoglobulin M deficiency
Dermatomyositis
Crohn disease
Complement deficiency
Lupus nephritis
Thymus histology
Lymph node histology
Spleen histology
Respiratory alkalosis

Transcript

Watch video only

Shigella is a Gram-negative bacterium that belongs to the Enterobacteriaceae family.

There are 4 species of Shigella:

S. dysenteriae, S. flexneri; S. boydii; and S. sonnei, and each has its own serotypes.

In humans these species can all cause Shigellosis, which is a contagious infection of the intestines, particularly the colon.

And shigellosis can progress to dysentery, which is when the infection causes inflammation of the colon, resulting in severe abdominal pain and diarrhea.

Now, Shigella is a gram-negative, rod shaped bacterium, meaning it looks like a little red or pink stick on a gram stain.

And it’s a facultative anaerobe, so it can survive with or without oxygen in the environment.

It has no flagellum, making it nonmotile; and it doesn’t form spores.

It’s also a non-lactose fermenter, so it doesn’t ferment lactose; and it’s urease and oxidase-negative, meaning it doesn’t produce these enzymes.

Finally, it doesn’t produce hydrogen sulfide gas either, and this can be used to selectively identify Shigella on special culture mediums like MacConkey agar.

On this medium, Shigella mostly forms white, non-lactose fermenting, non-hydrogen sulfide-producing colonies

Now, once Shigella is ingested, it multiplies in the small intestine, and then passes into the colon.

There, it targets the epithelial layer of the mucosal lining where it infects colonic enterocytes and microfold cells, or M-cells.

And these M-cells phagocytose, which means they eat the bacteria from the intestinal lumen, and then spit it out into the underlying mucosa-associated lymphoid tissues, or MALTs.

MALTs are a type of mucosal immune tissue that extends into the submucosa, and contains plenty of immune cells like macrophages.

The macrophages gobble up Shigella to neutralize the pathogen, but the bacterium induces apoptosis, or programmed cell death, in the macrophage.

Now, when a macrophage dies, it releases a variety of cytokines, including IL-1β, which activates an intense inflammatory process that recruits additional immune cells to wage war at the site of infection.

And this results in the death of epithelial cells, which damages the colonic mucosa, resulting in ulcerations and abscesses.

All the damage and migration of immune cells, particularly polymorphonuclear leukocytes, through the epithelium disrupts the cellular junctions between neighboring epithelial cells, allowing Shigella from the intestinal lumen to enter enterocytes through the lateral sides of the cell.

And actually, that’s not the only way Shigella can infect enterocytes after the initial infection:

After Shigella kills the macrophage and is released into the immune tissue under the epithelium, it can access and infect colonic enterocytes from their basal side.

Shigella uses its type III secretory system, which acts almost like a syringe, to puncture and inject proteins into enterocytes that makes the enterocytes phagocytose Shigella.

So that means Shigella is slowly engulfed by the cell membrane, forming a membrane bound compartment that eventually pinches off from the cell membrane and ends up inside the cell, where it’s called a phagosome.

Then, Shigella can use a number of effector proteins, which lyse the phagosome and release Shigella into the cytoplasm.

In the cytoplasm, effector proteins also induce Shigella’s actin-based motility.

This starts by recruiting the host cell’s small actin filaments to one end of the bacteria.

And as more and more actin filaments get recruited and polymerize behind the bacteria’s end pole, that propels the bacteria forward, like a rocket.

That helps Shigella “blast” through the lateral sides of both the host enterocyte and, after, the neighboring enterocyte, further spreading the infection.

Finally, one particular species of Shigella, S. dysenteriae serotype 1, also produces Shiga toxin.

Shiga toxin, similar to the shiga-like toxin producing pathotype of E. coli, is an AB toxin, so it has two main subunits, A and B, that are joined by a disulfide bond.

Each subunit plays a specific role in the invasion and destruction of a host cell.

The B subunit helps bind the toxin to the host’s cell membrane, where the toxin is ultimately engulfed into a phagosome.

Within the host’s cell cytoplasm, the inside of the phagosome becomes more acidic, and as a consequence, the disulfide bond holding the two subunits together becomes weak and eventually break, separating the subunits.

At this point, the A subunit can then diffuses through the phagosome membrane into the cytoplasm, where it targets the ribosomes.

In eukaryotic cells, ribosomes are made of two main subunits; the larger of the two is the 60S subunit, and it contains a 28S rRNA protein that’s important for the initiation of polypeptide synthesis.

Key Takeaways

Shigella is a genus of bacteria known to cause a contagious form of gastroenteritis known as shigellosis. Shigellosis is characterized by an inflammation of the gastrointestinal tract, which causes destruction and inflammation of the epithelium, leading to dysentery with symptoms like severe abdominal and rectal cramping and pain, a fever, and watery diarrhea with mucous with or without blood or pus. Shigella is transmitted through the fecal-to-oral route, mainly through fingers, food, and flies. It's diagnosed with a fecal sample and treatment centers around fluid and electrolyte replenishment and antibiotics.